Kinamycin B
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Antibiotics |
Catalog number | BBF-01547 |
CAS | 35303-13-0 |
Molecular Weight | 412.35 |
Molecular Formula | C20H16N2O8 |
Purity | >98% |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Kinamycin B is produced by the strain of Str. murayamaensis. Kinamycin B has antibacterial and mycobacterial effects, but it has weak activity against gram-negative bacteria.
- Specification
- Properties
- Reference Reading
- Price Product List
Synonyms | BRN 0503790; (1R,2R,3R,4S)-2-acetyloxy-11-diazonio-1,3,4,10-tetrahydroxy-2-methyl-9-oxo-3,4-dihydro-1H-benzo[b]fluoren-5-olate |
IUPAC Name | [(1R,2R,3R,4S)-11-diazo-1,3,4,9-tetrahydroxy-2-methyl-5,10-dioxo-3,4-dihydro-1H-benzo[b]fluoren-2-yl] acetate |
Canonical SMILES | CC(=O)OC1(C(C(C2=C(C1O)C(=[N+]=[N-])C3=C2C(=O)C4=C(C3=O)C(=CC=C4)O)O)O)C |
InChI | InChI=1S/C20H16N2O8/c1-6(23)30-20(2)18(28)13-11(17(27)19(20)29)10-12(14(13)22-21)16(26)9-7(15(10)25)4-3-5-8(9)24/h3-5,17-19,24,27-29H,1-2H3/t17-,18+,19+,20+/m0/s1 |
InChI Key | UZCOWBDCSCNWHJ-MTQWCTHYSA-N |
Appearance | Orange Acicular Crystalline |
Antibiotic Activity Spectrum | mycobacteria; Gram-negative bacteria |
Melting Point | 190-193°C |
BBF-03884 | Formononetin | Inquiry |
BBF-04301 | Tulathromycin A | Inquiry |
BBF-03880 | Cyclopamine | Inquiry |
BBF-01737 | Cordycepin | Inquiry |
BBF-03516 | (±)-Naringenin | Inquiry |
BBF-04609 | 1,1-Dimethylbiguanide hydrochloride | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
